| RNAi-based therapeutics and tumor targeted delivery in cancer G Kara, GA Calin, B Ozpolat Advanced drug delivery reviews 182, 114113, 2022 | 150 | 2022 |
| Preparation and characterization of novel albumin-sericin nanoparticles as siRNA delivery vehicle for laryngeal cancer treatment E Yalcin, G Kara, E Celik, FA Pinarli, G Saylam, C Sucularli, S Ozturk, ... Preparative Biochemistry and Biotechnology 49 (7), 659-670, 2019 | 35 | 2019 |
| Magnetically based nanocarriers in drug delivery EB Denkbaş, E Celik, E Erdal, D Kavaz, Ö Akbal, G Kara, C Bayram Nanobiomaterials in Drug Delivery, 285-331, 2016 | 35 | 2016 |
| Synthesis and characterization of amino acid-functionalized calcium phosphate nanoparticles for siRNA delivery F Bakan, G Kara, MC Cakmak, M Cokol, EB Denkbas Colloids and Surfaces B: Biointerfaces 158, 175-181, 2017 | 33 | 2017 |
| miRacle of microRNA-driven cancer nanotherapeutics G Kara, B Arun, GA Calin, B Ozpolat Cancers 14 (15), 3818, 2022 | 22 | 2022 |
| A microbial biosensor based on Lactobacillus delbruecki sp. bacterial cells for simultaneous determination of lactic and pyruvic acid E Canbay, A Habip, G Kara, Z Eren, E Akyilmaz Food Chemistry 169, 197-202, 2015 | 20 | 2015 |
| Downregulation of ABCE1 via siRNA affects the sensitivity of A549 cells against chemotherapeutic agents G Kara, S Tuncer, M Türk, EB Denkbaş Medical oncology 32, 1-11, 2015 | 19 | 2015 |
| Silencing of survivin and cyclin B1 through siRNA-loaded arginine modified calcium phosphate nanoparticles for non-small-cell lung cancer therapy G Kara, A Parlar, MC Cakmak, M Cokol, EB Denkbas, F Bakan Colloids and Surfaces B: Biointerfaces 196, 111340, 2020 | 17 | 2020 |
| Development of novel poly-l-lysine-modified sericin-coated superparamagnetic iron oxide nanoparticles as siRNA carrier G Kara, S Malekghasemi, B Ozpolat, EB Denkbas Colloids and Surfaces A: Physicochemical and Engineering Aspects 630, 127622, 2021 | 13 | 2021 |
| Nanobiomaterials in Drug Delivery EB Denkbaş, E Çelik, E Erdal, D Kavaz, Ö Akbal, G Kara, C Bayram William Andrew Publishing, 2016 | 11 | 2016 |
| Therapeutic potential of inhibiting ABCE1 and eRF3 genes via siRNA strategy using chitosan nanoparticles in breast cancer cells BB Cengiz, MD Asik, G Kara, M Turk, EB Denkbas Journal of Nanoparticle Research 17, 1-14, 2015 | 9 | 2015 |
| Magnetic gelatin nanoparticles as a biocompatible carrier system for small interfering RNA in human colorectal cancer: synthesis, optimization, characterization, and cell … A Selimovic, G Kara, EB Denkbas Materials Today Communications 33, 104616, 2022 | 8 | 2022 |
| Magnetically responsive, sorafenib loaded alginate microspheres for hepatocellular carcinoma treatment Ş Alpdemir, T Vural, G Kara, C Bayram, E Haberal, EB Denkbaş IET nanobiotechnology 14 (7), 617-622, 2020 | 8 | 2020 |
| Designing siRNA-conjugated plant oil-based nanoparticles for gene silencing and cancer therapy NM Anilmis, G Kara, E Kilicay, B Hazer, EB Denkbas Journal of Microencapsulation 36 (7), 635-648, 2019 | 8 | 2019 |
| Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo F Comert Onder, N Kahraman, E Bellur Atici, A Cagir, H Kandemir, ... ACS Pharmacology & Translational Science 4 (2), 926-940, 2021 | 6 | 2021 |
| Adaptive response to BET inhibition induces therapeutic vulnerability to MCL1 inhibitors in breast cancer G Yan, H Wang, A Luna, B Bozorgui, X Li, M Sanchez, Z Dereli, ... BioRxiv, 711895, 2019 | 6 | 2019 |
| MiR-329 mimic based nano-therapy inhibits growth and progression of triple negative breast cancer G Kara, N Kahraman, EB Denkbas, G Calin, B Ozpolat Cancer Research 80 (16_Supplement), 5985-5985, 2020 | 3 | 2020 |
| BET inhibition induces vulnerability to MCL1 targeting through upregulation of fatty acid synthesis pathway in breast cancer G Yan, A Luna, H Wang, B Bozorgui, X Li, M Sanchez, Z Dereli, ... Cell reports 40 (11), 2022 | 2 | 2022 |
| SPIONs: Superparamagnetic iron oxide-based nanoparticles for the delivery of microRNAi-therapeutics in cancer G Kara, B Ozpolat Biomedical Microdevices 26 (1), 1-15, 2024 | 1 | 2024 |
| In vivo miR-449b mimic-based nanotherapy suppresses growth and progression of triple-negative breast cancer G Kara, B Ozpolat Cancer Research 83 (7_Supplement), 3786-3786, 2023 | 1 | 2023 |
